enVVeno Medical (NASDAQ:NVNO) Announces Quarterly Earnings Results

enVVeno Medical (NASDAQ:NVNO) released its quarterly earnings results on Thursday. The company reported ($0.30) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.05, Zacks reports.

enVVeno Medical Price Performance

Shares of NVNO traded down $0.35 on Friday, reaching $3.18. The company’s stock had a trading volume of 239,342 shares, compared to its average volume of 111,170. enVVeno Medical has a 12-month low of $2.45 and a 12-month high of $6.97. The stock has a market capitalization of $55.76 million, a P/E ratio of -2.47 and a beta of 1.22. The stock’s 50 day simple moving average is $3.27 and its two-hundred day simple moving average is $3.70.

enVVeno Medical Company Profile

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).